PMID- 38393508 OWN - NLM STAT- Publisher LR - 20240223 IS - 1559-0100 (Electronic) IS - 1355-008X (Linking) DP - 2024 Feb 23 TI - Association between thyroid autoimmunity and bone mineral density in patients with type 2 diabetes mellitus: a cross-sectional study. LID - 10.1007/s12020-024-03733-3 [doi] AB - PURPOSE: The purpose of this study was to analyze the relationship between thyroid autoimmunity and bone mineral density (BMD) in patients with type 2 diabetes mellitus (T2DM), and to further explore the influence of thyroid autoimmunity on diabetic osteoporosis. METHODS: A total of 601 T2DM patients were included and divided into two groups according to thyroid autoantibodies, namely thyroid autoimmunity positive group (TPOAb+ or TGAb + ) and thyroid autoimmunity negative group (TPOAb- and TGAb-). Clinical data were collected and BMD was determined by dual-energy X-ray absorptiometry (DXA). SPSS26.0 software was used to data analysis. Model regression was used to analyze the influencing factors of BMD, and ROC curve was used to analyze the optimal cut-off point of thyroid peroxidase antibody (TPOAb) for screening osteoporosis. RESULTS: TPOAb and thyroglobulin antibody (TGAb) were negatively correlated with BMD and T-score (LS, FN and WB) (P < 0.01), and TGAb was negatively correlated with 25(OH)D (P < 0.05). Multiple linear regression analysis showed that TPOAb was an independent influence factor on LS, FN and WB BMD. ROC curve analysis showed that the optimal threshold of TPOAb for predicting osteoporosis was 12.35. CONCLUSIONS: In T2DM patients, TPOAb and TGAb levels are negatively correlated with LS, FN and WB BMD, and TPOAb is an independent influencing factor for diabetic osteoporosis, and TPOAb has a certain predictive value for the occurrence and development of diabetic osteoporosis clinically. CI - (c) 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. FAU - Wang, Zhen AU - Wang Z AD - The First School of Clinical Medicine, Lanzhou University, Lanzhou, 730000, Gansu, PR China. FAU - Bai, Jia AU - Bai J AD - The First School of Clinical Medicine, Lanzhou University, Lanzhou, 730000, Gansu, PR China. FAU - Zou, Jingyi AU - Zou J AD - The First School of Clinical Medicine, Lanzhou University, Lanzhou, 730000, Gansu, PR China. FAU - Yuan, Yue AU - Yuan Y AD - The First School of Clinical Medicine, Lanzhou University, Lanzhou, 730000, Gansu, PR China. FAU - Li, Shuyun AU - Li S AD - The First School of Clinical Medicine, Lanzhou University, Lanzhou, 730000, Gansu, PR China. FAU - Wang, Mengke AU - Wang M AD - The First School of Clinical Medicine, Lanzhou University, Lanzhou, 730000, Gansu, PR China. FAU - Lv, Haihong AU - Lv H AUID- ORCID: 0000-0003-2073-4899 AD - The First School of Clinical Medicine, Lanzhou University, Lanzhou, 730000, Gansu, PR China. haihonglv@126.com. AD - Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, 730000, Gansu, PR China. haihonglv@126.com. LA - eng GR - No. 2021JSCX0011/the Science and Technology Planning Project of Lanzhou Chengguan District/ GR - No. 2021JSCX0011/the Science and Technology Planning Project of Lanzhou Chengguan District/ GR - No. 23JRRA1499/Natural Science Foundation of Gansu Province/ PT - Journal Article DEP - 20240223 PL - United States TA - Endocrine JT - Endocrine JID - 9434444 SB - IM OTO - NOTNLM OT - Bone mineral density OT - Osteoporosis OT - Thyroid autoimmunity OT - Type 2 diabetes mellitus EDAT- 2024/02/23 12:43 MHDA- 2024/02/23 12:43 CRDT- 2024/02/23 11:15 PHST- 2023/09/22 00:00 [received] PHST- 2024/02/07 00:00 [accepted] PHST- 2024/02/23 12:43 [medline] PHST- 2024/02/23 12:43 [pubmed] PHST- 2024/02/23 11:15 [entrez] AID - 10.1007/s12020-024-03733-3 [pii] AID - 10.1007/s12020-024-03733-3 [doi] PST - aheadofprint SO - Endocrine. 2024 Feb 23. doi: 10.1007/s12020-024-03733-3.